Porta Daniela J, Carrillo Mariana N, Pérez Hernán A, Rivoira María A, Ledesma Grisel N, Muñoz Sonia E, Aballay Laura R, Armando Luis J, Schelling Jeffrey R, Spence J David, García Néstor H
Institute of Research in Health Sciences and National Research Council Scientific and Technical (INICSA-CONICET), Ciudad Universitaria, Córdoba, X5016, Argentina.
Facultad de Medicina, Universidad Católica de Córdoba, Ciudad de Córdoba, Córdoba, X5004FHP, Argentina.
J Nephrol. 2025 Jan;38(1):207-214. doi: 10.1007/s40620-024-02146-9. Epub 2024 Nov 23.
Chronic kidney disease (CKD) increases cardiovascular risk, however, traditional cardiovascular risk factors cannot entirely explain it. A real-world investigation examined the concept that renal function decline is linked to carotid total plaque area progression, which strongly confirms cardiovascular risk. We analyzed CKD patients in stages 1-3 to find risk factor relationships before the onset of severe CKD.
We monitored 328 patients for 16 ± 5 months. Participants were classified at baseline by estimated glomerular filtration rate (eGFR) stage: G1 (≥ 90), G2 (60-89), and G3 (30-59 ml/min/1.73m). Ultrasound-guided total plaque area tracked atherosclerosis. Age, sex, blood pressure, lipids, and HbA1c were covariates. Total plaque area and variables were measured on day 1 and at the conclusion of observation. We used a multilevel mixed effects model to assess biological and behavioral factors on total plaque area progression in the general population. For validation, this research was conducted on 73 CKD patients with optimal traditional cardiovascular risk factor management during 15 ± 5 months.
Multiple analyses showed an inverse relationship between eGFR decline and total plaque area progression [β-exponent = 0.99 (95% CI = 0.98-0.99)], regardless of age, lipid profile, blood pressure, smoking, diabetes, or hypertension. The correlation remained significant in the 73-patient sample with optimal traditional cardiovascular risk factor management (β-exponent = 0.99; 95% CI 0.97-0.99). Although traditional cardiovascular risk factor management was excellent, total plaque area increased considerably in G2-G3 patients compared to G1.
CKD, total plaque area, and eGFR are inversely correlated, independent of traditional cardiovascular risk factors, suggesting that non-traditional mechanisms are responsible for resistant atherosclerosis. The combination of eGFR and total plaque area may be useful in identifying high-risk patients.
慢性肾脏病(CKD)会增加心血管疾病风险,然而,传统的心血管疾病风险因素并不能完全解释这一现象。一项真实世界调查研究了肾功能下降与颈动脉总斑块面积进展相关的概念,这有力地证实了心血管疾病风险。我们分析了1-3期CKD患者,以找出严重CKD发作前的风险因素关系。
我们对328名患者进行了16±5个月的监测。参与者在基线时根据估计肾小球滤过率(eGFR)阶段进行分类:G1(≥90)、G2(60-89)和G3(30-59ml/min/1.73m²)。超声引导下的总斑块面积追踪动脉粥样硬化情况。年龄、性别、血压、血脂和糖化血红蛋白为协变量。在第1天和观察结束时测量总斑块面积及各项变量。我们使用多级混合效应模型评估一般人群中影响总斑块面积进展的生物学和行为因素。为进行验证,本研究对73名CKD患者进行了为期15±5个月的研究,这些患者的传统心血管疾病风险因素得到了最佳管理。
多项分析显示,eGFR下降与总斑块面积进展呈负相关[β指数=0.99(95%CI=0.98-0.99)],无论年龄、血脂水平、血压、吸烟、糖尿病或高血压情况如何。在73名传统心血管疾病风险因素得到最佳管理的患者样本中,这种相关性仍然显著(β指数=0.99;95%CI 0.97-0.99)。尽管传统心血管疾病风险因素管理良好,但与G1期患者相比,G2-G3期患者的总斑块面积仍显著增加。
CKD、总斑块面积和eGFR呈负相关,独立于传统心血管疾病风险因素,这表明非传统机制是导致难治性动脉粥样硬化的原因。eGFR和总斑块面积的联合使用可能有助于识别高危患者。